Drug intelligence / Profile preview

inulin-propionate ester

Development stage
Unknown
Lead developer
Imperial College London
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

Inulin-propionate ester (IPE) is a chemically modified dietary fiber designed to deliver the short-chain fatty acid propionate directly to the colon. It consists of inulin (a fermentable oligosaccharide) chemically bonded to propionic acid. The primary mechanism of action is targeted colonic release of propionate, which stimulates the secretion of anorectic gut hormones peptide YY (PYY) and glucagon-like peptide 1 (GLP-1), leading to increased satiety and reduced appetite. Clinical studies have shown that IPE supplementation can reduce energy intake, prevent weight gain over several months, improve insulin sensitivity, and modulate gut microbiota composition and systemic inflammatory responses in overweight or obese adults[5][8][6]. However, recent large-scale trials have questioned its effectiveness for long-term weight management in younger adults[10]. IPE is considered a novel food ingredient rather than a pharmaceutical drug.

Other names
IPEinulin propionate ester
02

Targets

FFAR2FFAR3 (Free fatty acid receptor 3)

Beyond the preview

Go deeper on inulin-propionate ester.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on inulin-propionate ester.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call